Secretion of IL-6 promotes TGFβ-mediated EMT in ovarian cancer via the JAK2/STAT3 pathway and leads to the inhibition of apoptosis and paclitaxel resistance [371]. This evidence concerns the gene TGFB1 and ovarian carcinoma.